SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641489-24-000016
Filing Date
2024-03-14
Accepted
2024-03-14 08:01:07
Documents
4
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1710417659.html 3  
1 FORM 3 wk-form3_1710417659.xml 3 1636
2 EX-24 powerofattorney-secfilin.htm EX-24 4223
3 powerofattorney-secfilin001.jpg GRAPHIC 235215
4 powerofattorney-secfilin002.jpg GRAPHIC 44395
  Complete submission text file 0001641489-24-000016.txt   392751
Mailing Address C/O TREVENA, INC. 1018 WEST 8TH AVENUE KING OF PRUSSIA PA 19406
Business Address
Phillips Anne M. (Reporting) CIK: 0001627680 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37524 | Film No.: 24747979

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)